Global Digital Diabetes Management Industry Trends and Market Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the digital diabetes management market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Digital Diabetes Management Market show for the 2026–2030 period?
The digital diabetes management market size has expanded significantly in recent years. This market is set to increase from $19.19 billion in 2025 to $23.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 25.0%. Historically, this growth has been fueled by factors including the increasing global burden of diabetes, restricted access to continuous clinical care, the surge in smartphone adoption, a rising demand for self-management tools, and the wider availability of digital health solutions.
The digital diabetes management market is projected to experience significant expansion over the coming years. This market is anticipated to reach a valuation of $58.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 24.8%. Several factors are contributing to this growth during the forecast period, including the growing adoption of AI in diabetes care, the broadening of remote patient monitoring, increased acceptance of telehealth services, integration with electronic health records, and the demand for personalized diabetes management solutions. Key trends expected during this period involve the swift uptake of remote diabetes monitoring platforms, the incorporation of AI-based glucose analytics, the proliferation of mobile diabetes management applications, a rise in the use of wearable diabetes devices, and the advancement of telemedicine-based diabetes care.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3414&type=smp
What Drivers Are Shaping The Development Of The Digital Diabetes Management Market?
The rising prevalence of diabetes is projected to stimulate the expansion of the digital diabetes-management market. Diabetes is a metabolic ailment characterized by elevated blood glucose levels, most commonly type 2, hindering the body’s capacity to utilize or generate insulin. The surge in diabetes cases is primarily attributed to escalating obesity rates, which considerably boost insulin resistance and elevate the risk of developing type 2 diabetes. This rapid growth in diabetes is consequently fueling demand within the digital diabetes-management industry, as companies increasingly deploy remote monitoring tools, app-based tracking, and tailored digital coaching to assist individuals in managing their condition more effectively. As an illustration, in June 2024, data from NHS England, a UK-based government agency, indicated a nearly 25% increase in individuals under 40 at risk of type 2 diabetes, rising from 173,166 in 2022 to 216,440 in 2023. Thus, the escalating prevalence of diabetes is a key driver for the digital diabetes management market.
What Segment Types Are Examined In The Digital Diabetes Management Market?
The digital diabetes management market covered in this report is segmented –
1) By Product And Service: Devices, Application, Data Management Software And Platforms, Services
2) By Device Type: Handheld Devices, Wearable Devices
3) By End User: Self Or Home Healthcare, Hospitals And Specialty Diabetes Clinics, Other End Users
Subsegments:
1) By Devices: Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGM), Insulin Pumps, Smart Insulin Pens, Diabetes Testing Strips
2) By Application: Diabetes Management Apps, Lifestyle And Diet Management Apps, Glucose Tracking Apps, Insulin Dose Adjustment Apps, Exercise And Activity Tracking Apps
3) By Data Management Software And Platforms: Cloud-Based Diabetes Management Platforms, Data Analytics Platforms, Electronic Health Record (EHR) Integrated Systems, Patient Management Software, Remote Monitoring Software
4) By Services: Telemedicine And Virtual Consultation Services, Remote Monitoring Services, Diabetes Education Services, Diabetes Coaching And Support Services, Clinical Decision Support Services
Which Market Trends Are Opening Growth Opportunities In The Digital Diabetes Management Market?
Leading companies operating within the digital diabetes management market are prioritizing the development of advanced solutions, such as long-term implantable continuous glucose monitoring (CGM) systems. These efforts aim to ease patient burden, improve real-time glucose surveillance, and enhance overall diabetes management. Long-term implantable CGM systems refer to medical devices inserted beneath the skin that continuously track glucose levels for extended periods, providing reliable data without requiring frequent sensor replacements, unlike traditional short-term CGMs. For instance, in September 2024, Senseonics Holdings, Inc., a US-based medical technology firm, obtained FDA clearance for Eversense 365, which is the world’s first fully implantable CGM sensor with a 365-day lifespan. Designed for individuals with type 1 and type 2 diabetes aged 18 and older, this system transmits glucose readings every five minutes to a mobile app, necessitates only weekly calibration after the initial two weeks, and includes a removable transmitter. This durable solution minimizes life disruption, reduces the need for sensor changes, and supports integration with automated insulin delivery (AID) systems, offering a more seamless and accurate approach to digital diabetes management.
Who Are The Top-Performing Companies In The Digital Diabetes Management Market In Recent Years?
Major companies operating in the digital diabetes management market are Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report
Which Region Currently Holds The Largest Share Of The Digital Diabetes Management Market?
North America was the largest region in the digital diabetes management market in 2025. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Digital Diabetes Management Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3414&type=smp
Browse Through More Reports Similar to the Global Digital Diabetes Management Market 2026, By The Business Research Company
Artificial Intelligence In Diabetes Management Market Report 2026
Diabetes Care Devices Market 2026
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market
Digital Health Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-health-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
